Valuation: Phosphagenics Limited

Market Cap 76.61M 52.95M 46.45M 42.88M 39.63M 75.11M 5.07B 515M 200M 2.48B 199M 195M 8.61B P/E 2024
-2.5x
P/E 2025 -6.43x
Enterprise Value 71.96M 49.74M 43.63M 40.28M 37.22M 70.55M 4.76B 484M 188M 2.33B 187M 183M 8.09B EV / Sales 2024
5.85x
EV / Sales 2025 23x
Free-Float
76.76%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - 30/04/2020
Chief Operating Officer - 30/04/2020
Corporate Secretary - 30/04/2026
Director TitleAgeSince
Director/Board Member - 12/04/2015
Chairman - 31/12/2018
Director/Board Member 59 25/04/2024
Change 5-day change 1-year change 3-year change Capi.($)
-14.29%-14.29% - - 52.95M
-1.60%+2.02%+56.34%+168.94% 1,084B
-1.44%+3.71%+69.07%+65.40% 634B
-0.75%+0.67%+33.18%+86.52% 447B
-0.34%-2.37%+28.23%+25.69% 330B
-9.07%-11.60%+24.03%+26.25% 295B
-0.55%-2.31%+28.20%+45.79% 285B
-1.00%-3.63%-27.78%-39.73% 218B
-0.03%+1.84%+23.90%+68.30% 199B
-0.40%+7.82%+22.29%+82.50% 169B
Average -2.38%+2.52%+28.61%+58.85% 406.65B
Weighted average by Cap. -0.54%+2.48%+40.05%+85.07%

Financials

2024 2025
Net sales 1.13M 783K 687K 634K 586K 1.11M 74.97M 7.62M 2.96M 36.69M 2.94M 2.88M 127M 1.24M 856K 750K 693K 640K 1.21M 81.92M 8.33M 3.24M 40.09M 3.21M 3.14M 139M
Net income -3.12M -2.16M -1.89M -1.75M -1.61M -3.06M -207M -21.01M -8.16M -101M -8.1M -7.93M -351M -4.42M -3.05M -2.68M -2.47M -2.28M -4.33M -292M -29.72M -11.55M -143M -11.46M -11.21M -497M
Net Debt -1.3M -897K -787K -726K -671K -1.27M -85.9M -8.73M -3.39M -42.04M -3.37M -3.3M -146M -4.65M -3.21M -2.82M -2.6M -2.4M -4.56M -308M -31.28M -12.15M -151M -12.07M -11.8M -523M
Logo Phosphagenics Limited
Avecho Biotechnology Limited is an Australia-based biopharmaceutical company. The Company develops and commercializes human and animal health products using its proprietary drug delivery system called Tocopheryl Phosphate Mixture (TPM). TPM is derived from Vitamin E using proprietary and patented processes. The Company's segments include Production and Human Health. The Production segment manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health portfolio covers delivery of pharmaceutical products through gels, injectables and patches, including conduct of research and development activities. The Company's products pipeline includes Weaner Pig Starter TPM Premix, Poultry TPM Premix, Dairy TPM Premix, Daptomycin, Propofol, Veterinary Applications, among others. Its TPM products are commercialized under license: Voveran TPM Gel, Instanac TPM Gel, Vital ET, and Ashland TPM.
Employees
-